Print version

pdf Click to download

Search Pub Med

Back
009P Queen Elizabeth II Conference Centre London
BPS Winter Meeting 2009

 

 

The turkey β-adrenoceptor and turkey β4C-adrenoceptor, unlike the turkey β3C-adrenoceptor, have two agonist conformations

Jilllian Baker. University of Nottingham, Nottingham, United Kingdom.

 

Of the 3 human β-adrenoceptors (AR), the β1 and β2-AR have been shown to exist in at least 2 active agonist conformations (Baker 2005a and b). There are three turkey β-AR – turkey β (Aurbach etal., 1975), 3C and 4C (Chen et al., 1994). This study looked for evidence of whether the 3 turkey β-ARs exist in different agonist conformations.

CHO-K1 cells were transfected with either the original full length turkey β-AR, the turkey β3C-AR or β4C-AR. The full length turkey β-AR did not express so a construct with 59 amino acids deleted from the C-terminus was transfected (tβtrunc; Warne et al., 2008). Stable clonal cell lines were made by dilution cloning. 3H-cAMP accumulation was performed as previously described (Baker 2005b).

Cyanopindolol (CYP) and CGP 12177 stimulated responses best described by a two-component curves for both the tβtrunc and tβ4C AR. The CYP and CGP 12177 responses in the tβ3C-AR were however best described by a single site sigmoidal concentration response curve. The inhibition of cimaterol by CGP 12177 for the tβ3C-AR (Fig C) can be expected by a competition at the same site. However, the pattern of inhibition of cimaterol by CGP 12177 at the tβtrunc-AR (Fig A) and tβ4C-AR (Fig B) can only be explained by the presence of at least two active conformations.

Thus, the turkey βtrunc and tβ4C-AR appear to exist in two active agonist conformations. As yet there is no evidence of more that one active agonist conformation for the tβ3C-AR.

ARtβtruncLog EC501Log EC502% site 1% isop max
tβt CYP -10.84±0.07 -7.41±0.04 65.9±1.5 36.6±3.4 4
CGP12177 -9.46±0.11 -7.40±0.10 59.4±2.2 42.7±2.6 4
tβ3C CYP -10.60±0.13 4.6±0.7 5
CGP12177 -9.38±0.16 5.3±0.4 5
tβ3C CYP -9.81±0.14 -7.20±0.20 44.4±2.0 16.4±2.7 5
CGP12177 -8.73±0.12 -6.58±0.15 41.3±7.2 17.4±0.7 4

 

Table. Log EC50 values and % max isoprenaline responses for 3H-cAMP accumulation responses

 

Aurbach GD, Spiegel AM, Gardner JD. (1975) Adv Cyclic Nucleotide Res. 5:117-132.
Baker JG (2005a). J Pharmacol Exp Ther 313: 1163-1171
Baker JG (2005b). Mol Pharmacol 68: 1645-1655.
Chen XH, Harden TK, Nicholas RA. (1994) J Biol Chem. 269: 24810-9.
Warne T et al., (2008) Nature 454: 486-491
JGB is a Wellcome Trust Clinician Scientist